Lupus-type illness associated with labetalol.
作者信息
Griffiths I D, Richardson J
出版信息
Br Med J. 1979 Aug 25;2(6188):496-7. doi: 10.1136/bmj.2.6188.496-d.
Abstract
摘要
相似文献
1
Lupus-type illness associated with labetalol.
Br Med J. 1979 Aug 25;2(6188):496-7. doi: 10.1136/bmj.2.6188.496-d.
2
SLE syndrome, probably induced by labetalol.
Postgrad Med J. 1981 Mar;57(665):189-90. doi: 10.1136/pgmj.57.665.189.
3
[Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa].
J Pharmacol. 1983;14 Suppl 2:61-6.
4
Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
J Rheumatol. 1980 Jul-Aug;7(4):544-6.
5
Procainamide and lupus erythematosus.
J Maine Med Assoc. 1973 Mar;64(3):54-5 passim.
6
[Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
Ann Med Psychol (Paris). 1975 Feb;1(2):237-48.
7
[Acebutolol and a lupus syndrome. Apropos of a case].
Therapie. 1984 Sep-Oct;39(5):571-5.
8
[Studies on systemic lupus erythematosus. (I) On experimental production of antinuclear factors by drugs and DNA-administration and renal immunohistology (author's transl)].
Nihon Jinzo Gakkai Shi. 1977 Jun;19(6):391-400.
9
[Drug-induced lupus. Study in a community of mental patients].
AMB Rev Assoc Med Bras. 1975 Jan;21(1):12-6.
10
Labetalol in hypertension.
Lancet. 1978 Feb 25;1(8061):452-3. doi: 10.1016/s0140-6736(78)91253-9.
引用本文的文献
1
Acetylator phenotype and lupus erythematosus.
Clin Pharmacokinet. 1981 Mar-Apr;6(2):118-34. doi: 10.2165/00003088-198106020-00003.
2
SLE syndrome, probably induced by labetalol.
Postgrad Med J. 1981 Mar;57(665):189-90. doi: 10.1136/pgmj.57.665.189.
3
Fatal bone-marrow suppression associated with captopril.
Br Med J (Clin Res Ed). 1981 Sep 19;283(6294):791-2. doi: 10.1136/bmj.283.6294.791-b.
4
Pharmacology of combined alpha-beta-blockade. I.
Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003.
5
Hypotensive agents, beta-blockers, and drug-induced lupus.
Br Med J (Clin Res Ed). 1982 May 8;284(6326):1358-9. doi: 10.1136/bmj.284.6326.1358.
6
Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
Cardiovasc Drugs Ther. 1988 Sep;2(3):343-53. doi: 10.1007/BF00054642.
Zotero 插件